Medical Dialogues

Tralokinumab Effective Across Racial Groups in Atopic Dermatitis: Phase III Analysis

USA: A post-hoc analysis of phase III clinical trials suggests that tralokinumab demonstrates consistent efficacy and a ...

Avecho completes treatment phase for Phase III insomnia trial interim analysis

Avecho Biotechnology Ltd (ASX:AVE, OTC:AVEFF, FRA:OEZ) has completed the treatment phase for the final patient required for ...
ascopubs.org

Primary overall survival analysis of the phase 3 randomized ZUMA-7 study of axicabtagene ciloleucel versus standard-of-care therapy in relapsed/refractory large B-cell lymphoma.

First phase 3 results from CARTITUDE-4: Cilta-cel versus standard of care (PVd or DPd) in lenalidomide-refractory multiple myeloma. This is an ASCO Meeting Abstract from the 2023 ASCO Annual Meeting ...
The New England Journal of Medicine

A Phase 3 Trial of Atacicept in Patients with IgA Nephropathy

IgA nephropathy, the most common primary glomerulopathy worldwide, is a kidney disorder of B-cell origin characterized by mesangial accumulation of IgA-containing immune complexes. In at least 50% of ...
ascopubs.org

EV-302: Updated analysis from the phase 3 global study of enfortumab vedotin in combination with pembrolizumab (EV+P) vs chemotherapy (chemo) in previously untreated locally ...

Neoadjuvant treatment with disitamab vedotin plus perioperative toripalimab in patients with muscle-invasive bladder cancer (MIBC) with HER2 expression: Updated efficacy and safety results from the ...

Veru outlines Q1 2027 interim readout for 36-week enobosarm plateau analysis

Q2 fiscal 2026 Management View "Veru is a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases," said ...